Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Dovetailing nicely with the continuing demand for generic drug products, Sandoz has completed a $10 million expansion at its Wilson, North Carolina, Center of Excellence site. The project added 30,000 square feet to the 170,000-square-foot facility. Sandoz is the...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c36147) has announced the addition of the Espicom Business Intelligence Ltd report: Sandoz Generics Company Intelligence Report to their offering.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c36147) has announced the addition of the Espicom Business Intelligence Ltd report: Sandoz Generics Company Intelligence Report to their offering.
The 340B Prime Vendor Program, managed by HealthCare Purchasing Partners International® HPPI announced today that it has added global pharmaceutical leader Sandoz a division of Novartis to its growing list of companies providing drugs, supplies and medical devices to clinics, hospitals and health care programs for low-income Americans. HPPI's three-year...
WILSON -- Sandoz, part of Swiss drug maker Novartis, plans to spend $10 million to expand research and development and add 65 jobs here within ... WILSON -- Sandoz, part of Swiss drug maker Novartis, plans to spend $10 million to expand research and development and...
Sandoz, the generics division of drug maker Novartis, has invested US$13 million in a third production facility in India. The investment is part of the company's global expansion of production facilities.
NOVARTIS AG is reviving the name Sandoz as an umbrella brand for its global operations in generic medicines. Since the merger of Sandoz and Ciba-Geigy to form Novartis seven years ago, the 117 year-old Sandoz name has been used on only a...
This article is about the Novartis, The merges of Swiss firms Sandoz and Ciba. It defines the requirements of the merger. Before the merger, employees at Sandoz had relied on a combination of paper files, local servers, PCs, and a VMS system to store their research documentation. The...
-- US approval a breakthrough in goal of making high-quality and cost- effective follow-on biotechnology medicines available for patients -- Omnitrope now approved for treatment of growth disorders in children and adults in the US, the European Union and...
Sandoz, the generics division of drug maker Novartis, has invested US$13 million in a third production facility in India. The investment is part of the company's global expansion of production facilities. The new unit will ... Sandoz, the generics division of drug maker Novartis, has...
EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the U.S. District Court for the District of New Jersey, after considering legal briefs and supporting affidavits from all parties, ordered late on Friday that the temporary restraints contained in the Temporary Restraining Order ("TRO") previously issued by...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c21659) has announced the addition of Erythropoietin Current Market Dynamics & Future Outlook to their offering.
HOW do you create a world-class drugs company? Merge two medium-sized ones, sack 10,000 people and give the new entity the sort of name you would expect to find on a Japanese car. That, on the face of it, is what Switzerland's Sandoz and Ciba-Geigy areHOW do...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c44741) has announced the addition of Corporate Focus Healthcare: Novartis Q3 2006 to their offering.
MENLO PARK, Calif.--BUSINESS WIRE--January 6, 1997--SangStat, The Transplant Company (Nasdaq: SANG), announced today that its proprietary formulation of CYCLOSPORINE is bioequivalent to Sandoz' newest cyclosporine formulation, Neoral, in its pivotal bioequivalence trial. The Company filed an application for market clearance of its Neoral-bioequivalent CYCLOSPORINE with the U.S. Food and...
FAIRFIELD, N.J. -- The transfer of Unigene Laboratories, Inc. (OTCBB: UGNE) proprietary manufacturing technology to Novartis for manufacturing calcitonin has been completed successfully.
Sandoz Nutrition Corp. recognizes the importance of its R&D activities. Its R&D staff faces a productivity standard that aims for a minimum of 30% of company sales from new products developed within the past three years. Sandoz has been improving Sandoz Nutrition Corp. recognizes the importance of its R&D activities....
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
With AT&T Tech Support 360, you'll have certified, U.S. based technicians on call 24/7 to help keep your computers, connections, software and peripherals up to speed for just 82¢ a day.
